West Nile virus: Difference between revisions

From IDWiki
No edit summary
No edit summary
Line 1: Line 1:
 
== Background ==
 
== Background ==
   
  +
=== Virology ===
* Single-stranded positive-sense enveloped virus in the family [[Flaviviridae]] and genus [[Flavivirus]]
+
* Single-stranded positive-sense enveloped virus in the family [[Family::Flaviviridae]] and genus [[Genus::Flavivirus]], within the Japanese encephalitis serocomplex
  +
* Five lineages, of which only lineage 1 and 2 cause outbreaks in humans
  +
  +
=== Epidemiology ===
 
* Essentially worldwide distribution
 
* Essentially worldwide distribution
* Vector is [[Vector::mosquitoes]]
+
* Vector is [[Vector::mosquitoes]], particularly [[Culex]] mosquitoes
* Main reservoir is birds
+
* Main reservoir is birds, particularly crows, jays, magpies, and ravens; also horses
  +
** Humans are an incidental host and not generally involved in transmission
  +
* Disease in humans is seasonal, with most cases July through September
 
* As well as being vector-borne, can also be transmitted by blood transfusion, solid organ transplantation, and vertically
 
* As well as being vector-borne, can also be transmitted by blood transfusion, solid organ transplantation, and vertically
   
 
== Clinical Manifestations ==
 
== Clinical Manifestations ==
   
* Incubation period of [[Usual incubation period::3 to 14 days]]
+
* Incubation period of [[Usual incubation period::3 to 14 days]], with range of [[Incubation period range::2 to 21 days]]
* Up to 80% of infections are asymptomatic; of those with symptoms, [[fever]] is most common
+
* Up to 80% of infections are asymptomatic
  +
* Of the 20% with symptoms, [[fever]] is most common
  +
** Other common symptoms include headaches, generalized weakness, morbilliform or maculopapular rash (often occuring at defervescence), and myalgias
  +
** Less common symptoms include arthralgias, chills, eye pain, vomiting, diarrhea, and lymphadenopathy
  +
** Generally self-resolves within days to weeks with complete recovery, though fatigue may linger
  +
  +
=== West Nile Neuroinvasive Disease ===
 
* Some form of CNS disease develops in 1:150 people
 
* Some form of CNS disease develops in 1:150 people
** [[Meningoencephalitis]]
+
* [[Meningoencephalitis]]
  +
** [[Meningitis]] with usual presentation (nuchal rigidity, headache, photophobia, phonophobia, fever)
** [[Acute flaccid paralysis]]
 
  +
** [[Encephalitis]] with altered level of consciousness, lethargy, personality changes
** 10% mortality, with about half of survivors having neuropsychiatric sequelae
 
  +
* [[Acute flaccid paralysis]] with acute onset and rapidly-progressive limb weakness
  +
** Usually asymmetry, areflexic/hyporeflexic, with preserved sensation
  +
** Usually but not always in the context of meningoencephalitis
  +
* Also may have nausea/vomiting, myalgias, arthralgias, chills, rash, ataxia, visual disturbance, tremors, myoclonus, bulbar dysfunction
  +
* Usually self-resolves over weeks to months, but half have neuropsychiatric sequelae (including function/cognitive dysfunction and paralysis)
  +
** 10% mortality
   
 
== Differential Diagnosis ==
 
== Differential Diagnosis ==
Line 35: Line 53:
   
 
* Supportive care
 
* Supportive care
  +
  +
== Further Reading ==
  +
  +
* West Nile Virus: Review of the Literature. ''JAMA.'' 2013;310(3):308–315. doi:[https://doi.org/10.1001/jama.2013.8042 10.1001/jama.2013.8042]
   
 
[[Category:Flaviviridae]]
 
[[Category:Flaviviridae]]

Revision as of 09:41, 29 August 2023

Background

Virology

  • Single-stranded positive-sense enveloped virus in the family Flaviviridae and genus Flavivirus, within the Japanese encephalitis serocomplex
  • Five lineages, of which only lineage 1 and 2 cause outbreaks in humans

Epidemiology

  • Essentially worldwide distribution
  • Vector is mosquitoes, particularly Culex mosquitoes
  • Main reservoir is birds, particularly crows, jays, magpies, and ravens; also horses
    • Humans are an incidental host and not generally involved in transmission
  • Disease in humans is seasonal, with most cases July through September
  • As well as being vector-borne, can also be transmitted by blood transfusion, solid organ transplantation, and vertically

Clinical Manifestations

  • Incubation period of 3 to 14 days, with range of 2 to 21 days
  • Up to 80% of infections are asymptomatic
  • Of the 20% with symptoms, fever is most common
    • Other common symptoms include headaches, generalized weakness, morbilliform or maculopapular rash (often occuring at defervescence), and myalgias
    • Less common symptoms include arthralgias, chills, eye pain, vomiting, diarrhea, and lymphadenopathy
    • Generally self-resolves within days to weeks with complete recovery, though fatigue may linger

West Nile Neuroinvasive Disease

  • Some form of CNS disease develops in 1:150 people
  • Meningoencephalitis
    • Meningitis with usual presentation (nuchal rigidity, headache, photophobia, phonophobia, fever)
    • Encephalitis with altered level of consciousness, lethargy, personality changes
  • Acute flaccid paralysis with acute onset and rapidly-progressive limb weakness
    • Usually asymmetry, areflexic/hyporeflexic, with preserved sensation
    • Usually but not always in the context of meningoencephalitis
  • Also may have nausea/vomiting, myalgias, arthralgias, chills, rash, ataxia, visual disturbance, tremors, myoclonus, bulbar dysfunction
  • Usually self-resolves over weeks to months, but half have neuropsychiatric sequelae (including function/cognitive dysfunction and paralysis)
    • 10% mortality

Differential Diagnosis

Diagnosis

  • Serology
    • Serum or CSF for IgM antibodies is the standard test; usually positive by 3 to 8 days, and persist for 2 to 3 months
      • If submitted CSF, must also submit serum
    • May cross-react with other flaviviruses
    • Can be seronegative if immunosuppressed (e.g. rituximab), therefore may need to do PCR
  • PCR
    • RNA virus, therefore needs reverse transcriptase step (RT-PCR)
    • Can be done on serum, CSF, and tissue
  • On MRI, may have a slight preference for thalamus

Management

  • Supportive care

Further Reading